CA SB938

Replaces references to "dementia" with "major neurocognitive disorders" (MNCDs) as defined in the Diagnostic and Statistical Manual of Mental Disorders in conservatorship law.

Requires court findings by clear and convincing evidence before a conservator can authorize placement of a conservatee with MNCD in a secured perimeter residential care facility, including that the facility is the least restrictive appropriate placement.

Requires physician declarations supporting petitions to administer psychotropic medications to include the diagnosis, recommended medications, previously attempted treatments, expected effects on mental health, potential side effects including FDA black box warnings, and whether the conservatee and attorney had opportunity to provide input.

Mandates the Judicial Council adopt rules of court and develop forms by July 1, 2017 for implementation of these provisions.

Requires court investigators to annually investigate and report every two years on whether psychotropic medication authority remains warranted, with mandatory attorney notification if the conservatee objects or changes are warranted.